GSK Lifts Outlook After Sales Boost
GSK said its fourth-quarter sales topped £8 billion, thanks to its best-selling shingles vaccine, and raised its guidance for 2024.
GSK said its fourth-quarter sales topped £8 billion, thanks to its best-selling shingles vaccine, and raised its guidance for 2024.
Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.